Identity
- Security key
- 22363
- Ticker
- TCRT
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2005-08-24
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- TCRT
Detail
Enriched 2026-08-14 20:47
- Market cap
- $4,884,292
- Shares outstanding (class)
- 24,422,146
- Shares outstanding (weighted)
- 2,442,146
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 1
- Location
- FORT LAUDERDALE, FL
- Homepage
- https://www.alaunos.com
- Description
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.